Thursday, December 12, 2024

Analysis-7-Eleven battle shows resilience of Japan Inc’s family ties

Must read

By David Dolan and Rocky Swift

TOKYO (Reuters) – A rise in shareholder activism in Japan is poised to fuel a new wave of management buyouts by founding families, after the battle for 7-Eleven’s parent company prompted a $58 billion takeover offer from the Ito dynasty that built the retail giant.

Seven & i Holdings Vice President Junro Ito swooped in last month with an offer to take private the company founded by his late father in what would be the largest ever management buyout (MBO).

Ito’s “white knight” bid appears designed to keep Seven & i away from Canada’s Alimentation Couche-Tard, which announced a takeover proposal in August. The Circle K owner raised its bid for Seven & i by about 22% to $47 billion in October after its initial offer was rejected.

The scramble for Seven & i gives a taste of how deals are likely to develop in the years to come, industry experts say, as changes in Japan Inc’s corporate governance standards make delisting an increasingly compelling option.

A few years ago, companies could ignore unsolicited offers because they were protected by cross shareholdings – the practice of holding stakes in business partners to cement relationships.

But those holdings are now being sold off under a government push for better governance. Companies have also been told they should give serious consideration to credible buyout offers.

“Managers can no longer ignore shareholders as they could in the past. Cross shareholdings are being unwound all the time,” said Travis Lundy of Quiddity Advisors who publishes on the Smartkarma platform.

“MBOs are going to be more common,” Lundy said, adding the government’s guidelines on giving consideration to buyout offers were “a game changer”.

ALL IN THE FAMILY

Last year, Japanese deals where management took stakes, including MBOs, totalled $7.1 billion, the most in at least 36 years, LSEG data showed. The value has fallen from that peak this year, but remains at $1.7 billion.

Among recent deals, educational publisher and nursing home operator Benesse Holdings was taken private in an MBO by the founding Fukutake family and Swedish private equity firm EQT. Drugmaker Taisho Pharmaceutical was bought out by a member of its founding Uehara family.

MBOs are becoming an attractive option because the governance overhaul has created bigger burdens for listed firms, while being a public company no longer confers the status it once did, said Ulrike Schaede, a professor of Japanese business at the University of California San Diego.

Latest article